Management

Dr. Malgorzata Szerszeniewska

Chief Executive Officer

Szerszeniewska is a co-founder of EastHORN. Previously, she was president of AbCRO, Inc., an American-owned CRO operating in Europe. Prior to that Dr. Szerszeniewska spent more than 10 years at Covance, where she held various positions including Regional Resource Manager, Project Manager, Director of Strategic Development and Clinical Operations in Europe, and was responsible for development of the company’s Clinical Development Services in the European region.

Before joining the CRO industry, she worked as an Anesthesiology and Intensive Care Specialist at Warsaw University Hospital. Dr. Szerszeniewska’s therapeutic experience includes oncology, neurology, cardiovascular, psychiatry and gastrointestinal medicine. Dr. Szerszeniewska received her Medical Diploma from the Warsaw Medical University.

malgorzata.szerszeniewska@easthorn.eu

“After working for more than 25 years in the clinical trials industry, I still could not find a European CRO that fully utilized all the advantages that Europe offers in terms of patient enrollment and data quality. In starting EastHORN, I made it my personal mission to become more than just an average research partner, to develop into a company that is the go-to source for exceptional clinical trials in Europe. We are planning to achieve our goal through inviting exceptional people from the industry to join us and to share our values and philosophy. Advocating for a unique personal approach and devotion towards our clients’ needs, we commit ourselves to excellence in clinical trials.”

Dr. Alan Wood

Executive Chairman

Dr. Wood co-founded EastHORN. He has 30 years experience in pharmaceutical research and development, both in pharmaceutical companies and in CROs. Most recently, he was Senior Director, R&D Operations at Nicox SA, a French biotechnology company. Previously, Dr. Wood was General Manager, Europe and Asia-Pacific at Covance and prior to that at Quintiles in a range of general management roles. He started his clinical development career with Sandoz (now Novartis) in Switzerland.

Dr Wood graduated in pharmacy and pharmacology from the University of Otago, New Zealand.
alan.wood@easthorn.eu

“When we started EastHORN we focussed our activities in Central and Eastern Europe because that is where we are based, and this region is well-recognized as a location for high-quality clinical research.
Demand from our clients has encouraged us to expand to other countries in Western Europe with similar advantages: access to patients and high-quality investigator sites.
As we grow and expand our geographic reach we are determined to keep the characteristics of a small company: responsive, nimble, easy to work with, senior management involvement in operations and a commitment to the highest professional standards.”

Iain Gordon

Chief Business Officer

Iain joined EastHORN in 2013 to play a key role in the next stages of EastHORN’s ambitious plans for growth. He has been managing CRO business development in Europe and North America for more than 15 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services in this region and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry.

Iain is based in the UK and graduated in Cell Biology from the University of Glasgow.
iain.gordon@easthorn.eu

“Since joining the CRO industry in the 90’s I have been continually impressed with the quality and speed of clinical work in Europe. In an industry where timelines are absolutely key, but deadlines are often missed, I have lost count of the times that European operations and sites have saved the day. As this region matures it now offers the best of both worlds combining experience and dynamic enrolment, continually outperforming some of the more exotic and less predictable regions that have started to offer clinical services more recently.”

Christine Mohlberg

Head of Project Management

Ms Mohlberg joined EastHORN at the beginning of 2013 and established the office in Cologne, Germany to further enhance our services for Western European and German clients. She has worked in the clinical research field for over 16 years and is very aware of the important role of European countries in almost all clinical trials and the constant growth in the region

Having previously worked for both CROs and pharma companies, she is very familiar with the clinical research environment in Germany and internationally. With her understanding of the structure and needs, as well as challenges of the pharmaceutical industry, she ensures that the services delivered to our clients by our project teams are of the highest quality.

Ms Mohlberg graduated in biology from the University of Giessen, Germany
christine.mohlberg@easthorn.eu

“After working for almost 20 years in the clinical research industry at various companies, I still could not find a company that fully utilized the advantages that Europe offers in terms of patient recruitment and data quality, as well as the availability of talented people who always support their international colleagues. My personal mission is to run EastHORN as a company that can utilize the best features that global organizations offer, but is free from all of the drawbacks that sponsors often experience while working with larger organisations.

Dr. Tandy Amure

Chief Medical Officer

Dr Tandy Amure has over 24 years experience working as a physician within the CRO industry. She held posts as Clinical Research Physician and Principal Investigator at Phase I/Clinical Pharmacology units, before joining Covance in 1997, as Pharmaceutical Development Physician.

She had increasing roles and responsibilities during her 18 year tenure with Covance, working up to the position of Senior Medical Director, a position she held for 10 years. Dr Amure has extensive experience in medical monitoring, business development, process improvements, mentoring and client facing situations. She brings a wealth of experience in clinical development across multiple therapeutic areas and phases of clinical development.

Dr Amure is a Rheumatologist by training, and obtained her medical degree from the University of Bristol, UK in 1988. She also has a BSc (Hons) in Physiology and a Masters degree in Pharmacology.

Dr Amure is based in the UK, and is GMC Registered.

tandy.amure@easthorn.eu

When I joined the CRO Industry 24 years ago, it was not as global and far reaching as it is now, with less outsourcing, and fewer CROs vying for market share. My earlier appointments involved working within small teams and growing them in line with company expectations. There was a fluidity and flexibility which made decision making easier for the team and for our clients. I found this was a feature that was lacking in some companies as they grew in size. EastHORN is able to offer this fluidity and flexibility to judiciously meet clients needs.  Our goal is to apply the Medical, Scientific and Ethical rigour needed for all our clients clinical trials, delivered with integrity, in a consistent manner, at all times”.